|
CN111345423A
|
|
Solid anti-alcohol beverage and preparation method thereof
|
|
CN105319374A
|
|
Method and reagent kit for screening target protein nucleic acid ligand
|
|
CN105255862A
|
|
Oligonucleotides for preparation of drug for inhibiting tumor growth and use thereof
|
|
CN104974157A
|
|
Istradefylline synthesis process
|
|
CN104530055A
|
|
Preparation method of tofacitinib citrate
|
|
CN104459004A
|
|
Content determination and related substance detection method of tofacitinib citrate
|
|
CN104478790A
|
|
Preparation method of S-type apremilast
|
|
CN104523692A
|
|
Pomalidomide compound and preparation method thereof
|
|
CN104447572A
|
|
Method for preparing macitentan
|
|
CN104458961A
|
|
Apremilast related substance detection method
|
|
CN103655531A
|
|
Tapentadol (hydrochloride) oral solution and preparation method thereof
|
|
CN103655523A
|
|
Tapentadol composition
|
|
CN103598187A
|
|
Carboxylic acid halide amine antibacterial agent as well as synthetic method and application thereof
|
|
CN103553940A
|
|
Preparation method of new crystal form tapentadol hydrochloride
|
|
CN103257190A
|
|
Method for measuring buprofen/famotidine compound preparation content
|
|
CN103058991A
|
|
Preparation method of alpha-crystal form imatinib mesylate
|
|
CN103054822A
|
|
Imidafenacin tablet and preparation method thereof
|
|
CN103063795A
|
|
Methods for determining the content of imidafenacin and detecting related substances
|
|
CN102934799A
|
|
Healthcare product containing broad bean extracts and application of healthcare product
|
|
CN102928546A
|
|
Reversed high-efficiency liquid chromatography used for detecting roflumilast raw materials and impurity content thereof
|
